Gene: LVRN
Official Full Name: laeverinprovided by HGNC
Gene Summary: Predicted to enable metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Predicted to be involved in peptide catabolic process and proteolysis. Predicted to be active in cytoplasm; extracellular space; and membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33457 | LVRN Knockout cell line (HCT 116) | Human | LVRN | 1:2~1:4 | Negative | Online Inquiry |
LVRN Gene Knockout Cell Lines are precision-engineered cellular models specifically designed to study the functional impact of the LVRN gene by removing its expression through genetic knockout techniques. These cell lines enable researchers to investigate the biological role of the LVRN gene in various cellular processes, including differentiation, proliferation, and oncogenesis. By utilizing state-of-the-art CRISPR/Cas9 gene editing technology, these cell lines provide a reliable platform to assess the phenotypic changes resulting from the absence of the LVRN gene.
The key mechanism of action in LVRN Gene Knockout Cell Lines involves the introduction of CRISPR/Cas9 components into targeted cells, which lead to the precise disruption of the LVRN gene. This results in a loss of function, allowing scientists to delineate the gene's role in health and disease. The significance of these cell lines in scientific research cannot be understated; they offer a vital tool for elucidating the pathways involving LVRN, which may have implications in cancer research and genetic disorders.
Compared to traditional gene knockout methods, LVRN Gene Knockout Cell Lines significantly reduce the time and complexity involved in generating stable knockout models. Their ready-to-use nature allows researchers to focus on experimental design and data generation rather than time-consuming cell line development. This product stands out due to its high efficiency, reproducibility, and the ability to be used in a variety of cellular contexts, which is vital for translational research.
For researchers and clinicians aiming to explore the interplay of genetic factors and disease, LVRN Gene Knockout Cell Lines offer unparalleled value by enabling clear insights into gene function and facilitating the discovery of novel therapeutic targets. With our company’s robust expertise in genetic engineering and cell line development, we ensure that each product is of the highest quality, thus empowering discoveries that bridge the gap between laboratory research and clinical application.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.